A $4 million supercomputer is the Queensland government's latest addition to its already impressive investment in the state's biotech infrastructure assets. [ + ]

To streamline drug discovery and development in the face of mind-numbing amounts of data, the need for integration and interoperability among applications, databases, and hardware is greater than ever before, according to an array of speakers at the recent BioSilico 2002 conference. [ + ]

A team from the University of NSW is one of the members of a newly-formed international group set up to examine how the Linux operating system running on Hewlett-Packard servers can serve as a key platform for research. [ + ]

Singapore's Nanyang Technological University (NTU) and Compaq Computer Corp are to jointly build the infrastructure for Singapore's new Bioinformatics Research Centre (BIRC). [ + ]

The newly-formed Medical Device Network has become a formal program within industry association AusBiotech. [ + ]

Australia's dairy industry will milk the rewards from a cash injection of almost $1.3 million from the Geoffrey Gardiner Dairy Foundation. [ + ]

The Minister for Communications, IT and the Arts, Senator Richard Alston, has launched the commonwealth government's 'Smart Moves' outreach program, designed to promote research, innovation and entrepreneurship in science, engineering and technology.

A consortium of technology heavyweights and life sciences bodies has put the finishing touches on the group's agenda designed to make sending research data between organisations easier. [ + ]

Australian biotechnology company Ambri Ltd has appointed two executives to encourage new backing for the company's biological weapons detection contracts. [ + ]

Genetic Technologies (ASX: GTG) is expecting to finish the year in the black despite posting an interim profit loss yesterday. [ + ]

Half-year results for drug developer Progen Industries show the company enjoyed healthy revenue gains from its contract manufacturing arm while R&D spend rose slightly. [ + ]

An accelerated research program helped Aussie export Axon Instruments (ASX:AXN) drive sales up 25 per cent last year, but also contributed to a significant profit slump. [ + ]

Australia's first publicly-listed pure genomics research company, Bionomics Ltd, has interested a second northern hemisphere partner in its portfolio of patented genes. [ + ]

Bioengineering group Eiffel Technologies (ASX: EIF) has posted a more than three per cent fall in after-tax profits to $777,000 for the second half of last year. [ + ]

The SIA's National Council met in Melbourne on 21 February to decide on the association's goals for 2002. The SIA workplan for 2002 has been developed around the theme of 'inform, involve, influence'.